Bhaskar Anand

CIK 1890784 · Chief Accounting Officer · last filed 2026-01-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.24M

Companies

2

Total Filings

17

Lifetime Open-Market Net

-$554.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SMMT Chief Accounting Officer 159,751 $14.01 $2.24M $0 7 2026-01-12
REATA PHARMACEUTICALS INC (RETA) Delisted SVP, Chief Accounting Officer 0 $172.36 $0 -$554.3K 10 2023-09-26

Recent Filings · Page 2 of 2

17 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-06-16 REATA PHARMACEUTICALS INC (RETA) Delisted Mixed −781 -$196.6K EDGAR
2023-05-17 REATA PHARMACEUTICALS INC (RETA) Delisted Sell (S) −1,086 -$92.7K EDGAR
2023-03-08 REATA PHARMACEUTICALS INC (RETA) Delisted Sell (S) −165 -$14.0K EDGAR
2023-03-06 REATA PHARMACEUTICALS INC (RETA) Delisted Sell (S) −820 -$71.7K EDGAR
2023-03-02 REATA PHARMACEUTICALS INC (RETA) Delisted Grant (A) +3,000 $0 EDGAR
2023-01-04 REATA PHARMACEUTICALS INC (RETA) Delisted Grant (A) +8,250 $0 EDGAR
2022-01-05 REATA PHARMACEUTICALS INC (RETA) Delisted Grant (A) +12,500 $0 EDGAR
Showing 1117 of 17
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.